ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2981

Measurement of Tissue Damage in Scleroderma Using Digital Mammographic Xrays: A Proof of Concept Study

John Highton1, Terence Doyle2 and Simon Stebbings3, 1Dept of Medicine, University of Otago, Dunedin, New Zealand, 2Medicine, University of Otago, Dunedin, New Zealand, 3Dunedin School of Medicine, University of Otago, Dunedin, New Zealand

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: imaging techniques, outcome measures and scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: We have used digital mammographic soft tissue Xrays of the fingers from patients with Scleroderma and related conditons to show damage related to the disease.  Images clearly show skin thickening, fibrosis of subcutaneous tissues, calcinosis, tuft resorption and loss of tissue from the finger tips.  In this study we developed a scoring sytem to give a semi-quantitative measure of these changes to investigate the hypothesis that this method could be used as a damage index and outcome measure in Scleroderma.

Methods: A Sectra Microdose C30 machine was used to take digital soft tissue images with four-finger AP views and lateral views of the index and middle fingers.  Images were viewed by 2 authors and consensus reached on mild, moderate and severe changes (scored 1,2,3) for fibrosis, calcinosis and tuft resorption.  Skin thickness was measured at 3 sites in each finger and averaged.  Loss of tissue at the fingertip was measured according to Yune et al.  Measurements were converted to scores for consistency.

Results: Xrays were scored for 6 normal subjects, 15 with lcSSc, 1 MCTD (included with lcSSc) and 7 dcSSc.  Scores for calcification were higher in lcSSc for calcification: 1.2 vs 0.8 for dcSSc.  Scores for tuft resorption and skin thickening were higher in dcSSc vs lcSSc: 1.8 vs 1.1 and 1.9 vs 1.1.  Total damage scores were 0.17±0.1, 6.3±3.8 and 7.6±3.0 for normals, lcSSc and dcSSc respectively.  These values were not statistically different.  However, subjects with dcSSc had significantly more damage per year of disease duration: 1.2±0.8 vs 0.4±0.3, p=0.03.

Conclusion: We have explored the possibility that soft tissue Xrays of the fingers taken using digital mammographic methods could be used to produce a semiquantitative measure of tissue damage in Scleroderma, akin to a Sharp Index in RA.  The fact that we were able to demonstrate significantly faster accumulation of damage with dcSSc compared to lcSSc even in a small number of subjects provides proof of the concept and warrants further development of this method as an outcome measure in Scleroderma.


Disclosure: J. Highton, None; T. Doyle, None; S. Stebbings, None.

To cite this abstract in AMA style:

Highton J, Doyle T, Stebbings S. Measurement of Tissue Damage in Scleroderma Using Digital Mammographic Xrays: A Proof of Concept Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/measurement-of-tissue-damage-in-scleroderma-using-digital-mammographic-xrays-a-proof-of-concept-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/measurement-of-tissue-damage-in-scleroderma-using-digital-mammographic-xrays-a-proof-of-concept-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology